Treatment of Rett Syndrome With Recombinant Human IGF-1

NCT01777542 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Rett Syndrome

Interventions

DRUG: Recombinant Human Insulin Growth Factor 1 (rhIGF-1)
DRUG: Placebo

Sponsor

Boston Children's Hospital

Collaborators

[object Object]